Cure Ventures

Cure Ventures

Boston, Massachusettscurevc.com

Overview

Cure Ventures is a life sciences venture capital firm focusing on de novo company formation around groundbreaking curative technologies. The firm focuses on early-stage investments in life science and biotechnology, primarily focused in new therapeutics. Cure's unique approach also embraces genetic validation as part of an iterative process to guide a drug through development, increasing the probability of success and mitigating the cost of failure. Embedded Cure operators work alongside portfolio company founders to drive day-to-day decision making.

Year Founded

2021

Portfolio Companies

5

Website

curevc.com

Investments

CompanyDateStageLead
Tortugas NeuroscienceApr 2026SeedLead
Tasca TherapeuticsSep 2025Series ALead
Tasca TherapeuticsDec 2024Series ALead
Clasp TherapeuticsMar 2024Series ACo-investor
Kenai TherapeuticsFeb 2024Series ALead

Key People

Richard Lim

Managing Partner And Co-Founder

Albert J Robichaud

Partner

Annie Mitsak

Partner

Jeffrey Jonas

Partner

Jeno Gyuris

Partner

Kenzie MacIsaac

Partner

May Han

Partner

milenko cicmil

Partner

Bill Amsbaugh

Chief Technology Officer, Partner

Drew King

Partner And Chief Financial Officer

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.